Divis undertakes custom manufacture of APIs and production of advanced Intermediates offering a competitive advantage to its clients over the entire life cycle of the products.

It is a very common practice to find several MNC clients audit our facilities regularly in course of the custom manufacture of their products. This transparency in operation has resulted in increased confidence, trust and business between Divis and its clients.

With four R&D Centers, two Pilot Plants, two large scale manufacturing units including a cGMP / ISO / FDA accredited facility, Divis is an ideal partner for custom synthesis, process development and mass manufacturing of customer’s own discovery product.

Divis undertakes complete and acceptable validation of processes. Divis also offers its analytical and process expertise for generating reliable data for regulatory agencies [e.g. stability studies such as ICH] and its documentation expertise for preparing draft DMFs, CoS etc. for regulatory submissions.

Divis clients enjoy a great benefit from the foundations on which the entire company was built – the Divis Research Center.

With years of experience, experimentation and application, the scientists at Divis Research Center (DRC) are the right people to be tapped for contract research projects.

Over the years many an innovator company has leveraged the strength of DRC on a Full Time Equivalent (FTE) basis.

The Research team is specialized in process design for new drug candidates, development up to gram/kilo scale, structural elucidation, impurity profile studies, process validation, process justification, process optimization, analytical methods development and validation, environment impact analysis, safety studies and time cycle studies etc.

An engagement with DRC gives our clients the advantage to concentrate on actual invention and also gives them a team that has the capacity to re-evaluate and give a second opinion on the primary invention or discovery itself.